Company intelligence / Profile preview

Bio-Angle Vacs

Malaysia

Ownership: Private
Development stage: Other

Overview

Bio-Angle Vacs commercially supplies veterinary vaccines and related animal health products globally, including its flagship intranasal Spray Technology Vaccine (STVAC) for pneumonia in goats and sheep and multiple oral/feed-based vaccines for aquaculture, with reported multi-country sales contracts exceeding USD 80 million annually.[2]

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologicRecombinant protein
Industry: Veterinary

Partnerships

Fischer Medical Ventures (science, technology, marketing collaboration and planned India production facility)[2]Universiti Putra Malaysia, Faculty of Veterinary Medicine (co-development of STVAC)[2]College of Veterinary Medicine, Animal Resources and Bio-security (CoVAB), Makerere University, Uganda (partnership discussions for veterinary vaccines)[6]

Beyond the preview

Go deeper on Bio-Angle Vacs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Angle Vacs.

Explore the full profile